Related Experiment Video
Updated: Jun 6, 2026

Selected Reaction Monitoring Mass Spectrometry for Absolute Protein Quantification
Published on: August 17, 2015
Regulatory observations in bioanalytical determinations
1US FDA, Division of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, Rockville, MD 20857, USA. ct.viswanathan@fda.hhs.gov
Abstract:
The concept of measuring analytes in biological media is a long-established area of the quantitative sciences that is employed in many sectors. While academic research and R&D units of private firms have been in the forefront of developing complex methodologies, it is the regulatory environment that has brought the focus and rigor to the quality control of the quantitative determination of drug concentration in biological samples. In this article, the author examines the regulatory findings discovered during the course of several years of auditing bioanalytical work. The outcomes of these findings underscore the importance of quality method validation to ensure the reliability of the data generated. The failure to ensure the reliability of these data can lead to potential risks in the health management of millions of people in the USA.
Related Concept Videos
Data Validation
Key parameters for method validation include:
Measurement of Bioavailability: Pharmacodynamic Methods
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Bioequivalence Data: Statistical Interpretation
Measurement of Bioavailability: Pharmacokinetic Methods
Therapeutic Drug Monitoring: Drug Analysis Methods

